Connect with 750+ biotech and pharma leaders and the leading companies involved with clinical development and healthcare innovation at CNS Summit.
From digital therapeutics to advances in clinical trial operations, the pharmaceutical industry experiences rapid changes every day. Thanks to all of the new research and technology focused on improving pharma, many executives have trouble staying in the loop.
To remain competitive and stay up to date on the latest trends, executives, researchers, and regulators in the pharma and biotech industries attend CNS Summit. The annual conference features attendees from companies like Pfizer, Roche, Philips, Johnson & Johnson, Pear Therapeutics, and more.
If you want to learn about the latest pharma and clinical development innovations and to connect with other professionals in the field, CNS Summit is a cant-miss event.
Name of event: CNS Summit
Location: Boca Raton, Florida
Date: November 1st, 2018 - November 4th, 2018
Adam Dakin, Managing Director - Dreamit HealthTech
Adam serves as the Managing Director of Dreamit HealthTech, a leading venture-backed accelerator. His career has focused on building early stage venture-backed healthtech companies. Adam has held various senior management roles in sales, marketing, product development, clinical affairs, operations, and general management. He co-founded five health technology companies which have collectively raised over $60M in early stage capital. Prior to Dreamit, Adam served as CEO of PhotoSonix Medical, a venture-backed company he co-founded that is developing a consumer device for acne. Previously, he served as the CEO of Bioconnect Systems and X-SITE Medical (acquired by Maquet Getinge Group). Adam serves on the boards of Safkan Ear and ZSX Medical. He is an active angel investor and has served on the boards of several early stage health companies. He is the co-chair of the Philadelphia Alliance for Capital and Technology (PACT) medical technology advisory board and serves as a Mentor in Residence for the Penn Center for Innovation. Adam was awarded the PACT MedTech Leadership Award in 2014. He is a named inventor on seven U.S. patents. Adam holds a BSE from the Wharton School and an MBA from UCLA.